Karuna is a clinical-stage biopharmaceutical company committed to developing and delivering first-in-class therapies with the potential to transform the lives of people with CNS disorders – which remain among the most disabling and potentially fatal disorders worldwide. Galvanized by the understanding that today’s neuropsychiatric patients deserve better, Karuna’s mission is to harness the untapped potential of the brain’s complex biology in pursuit of novel therapeutic pathways that will advance the standard of care.

Biotechnology

Karuna Therapeutics

Bill Meury

Steven Paul

Tanya Glidden

Amanda Orban

Stephanie Hodges

Alicia Meli

Frank Truslow

Jackie Cohen

Gregg Pratt

Mia Kelley

Will Kane

Andrew Miller

Troy A. Ignelzi

Stephen Brannan

The Medical and Clinical Operations team at Karuna Therapeutics oversees the development and execution of clinical trials, manages medical science liaisons, ensures compliance with regulatory requirements, and provides essential medical information and support. This team collaborates closely with research scientists, regulatory bodies, and healthcare professionals to advance innovative therapies for CNS disorders, ensuring they meet high standards of safety and efficacy.

Medical and Clinical Operations

Directors

Leadership Team

Medical and Clinical Operations

About

Team members

Other teams at Karuna Therapeutics

Directors

Leadership Team